Heart Disease News and Research

Latest Heart Disease News and Research

Unconscious racial attitudes affect positive interactions leading to the detriment of patient health

Primary care physicians who hold unconscious racial biases tend to dominate conversations with African-American patients during routine visits, paying less attention to patients' social and emotional needs and making these patients feel less involved in decision making related to their health, Johns Hopkins researchers report.

16 Mar 2012

Serious climate change-related health problems will affect the world's population

Worldwide increases in the incidences of asthma, allergies, infectious and cardiovascular diseases will result from a variety of impacts of global climate change, including rising temperatures, worsening ozone levels in urban areas, the spread of desertification, and expansions of the ranges of communicable diseases as the planet heats up, the professional organization representing respiratory and airway physicians stated in a new position paper released today.

16 Mar 2012

More than 250 Montefiore physicians named Top Doctors by Castle Connolly

More than 250 doctors from Montefiore Medical Center have been named in the Top Doctors: New York Metro Area 2012 guide, by Castle Connolly Medical Ltd. The doctors selected were among thousands who had been nominated by their peers and judged on various criteria including medical education, training, hospital appointments and disciplinary histories.

16 Mar 2012

Introducing art into nursing care improves stroke survivors' QOL

Stroke survivors who like art have a significantly higher quality of life than those who do not, according to new research. Patients who appreciated music, painting and theatre recovered better from their stroke than patients who did not.

16 Mar 2012

Experts highlight latest advances in use of biomarkers in various diseases

Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.

16 Mar 2012

Depression increases risk of death in PCI patients

Depression increases the risk of death in patients who have a coronary stent implanted. After seven years of follow up, depressed patients were 1.5 times more likely to have died than non-depressed patients. The findings were independent of age, gender, clinical characteristics, anxiety and the distressed (Type D) personality.

16 Mar 2012

UM, Shock Trauma partner to train dental students, residents

The University of Maryland's (UM) School of Dentistry has teamed up with the UM School of Medicine's R Adams Cowley Shock Trauma Center for training future dentists to respond efficiently and effectively to life threatening medical emergencies in a dental setting.

16 Mar 2012

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

16 Mar 2012

OHRI, uOttawa to lead first stem cell therapy trial for septic shock

A team of researchers from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa) has been awarded $367,000 from the Canadian Institutes of Health Research (CIHR) and $75,000 from the Stem Cell Network to lead the first clinical trial in the world of a stem cell therapy for septic shock.

16 Mar 2012

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa.

16 Mar 2012

Health Canada approves Mylan-Rosuvastatin Calcium Tablets

Mylan Pharmaceuticals ULC, the Canadian subsidiary of Mylan Inc., today received approval from Health Canada for Mylan-Rosuvastatin Calcium Tablets, 5mg, 10mg, 20mg and 40mg. Mylan-Rosuvastatin is the generic version of Astra Zeneca's Crestor Tablets, which are used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia.

16 Mar 2012

Patients with early stage MPM may be eligible for aggressive multi-modality therapy

Patients with early stage malignant pleural mesothelioma (MPM), a cancer that develops in the lining of the lungs, may be eligible for aggressive multi-modality therapy involving surgery, radiotherapy and chemotherapy.

16 Mar 2012

Light-to-moderate drinking may reduce risk of stroke in women

Light-to-moderate alcohol consumption has been consistently associated with lower risk of heart disease, but data for stroke are less certain, especially among women.

16 Mar 2012

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

CSL Behring announced today that the first patient has been treated as part of the REPLACE Phase III clinical trial evaluating the efficacy and safety of fibrinogen concentrate (Human) (FCH) in controlling microvascular bleeding during aortic aneurysm surgery.

16 Mar 2012

diaDexus fourth quarter total revenues increase 48% to $4.9 million

diaDexus, Inc.a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced financial results for the 2011 fourth quarter and year-end.

16 Mar 2012

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the fourth quarter and 2011.

From Elekta 15 Mar 2012

Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter

Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.

15 Mar 2012

Seeds for heart-healthy soybean, canola and sunflower oils

With spring planting season on the horizon, scientists are planting the seeds of healthier oils for cooking French fries, fried chicken and other fried items prepared in restaurants and other settings in the foodservice industry.

15 Mar 2012

Shire enters agreement to acquire FerroKin BioSciences

Shire plc, the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100 million, payable in cash at closing, plus potential post-closing milestone payments of up to $225 million, depending upon the achievement of certain clinical development, regulatory and net sales targets.

15 Mar 2012

China Pharma revenue increases 9% to $81.2M for full year 2011

China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.

15 Mar 2012

Heart Disease News and Research

Latest Heart Disease News and Research

Unconscious racial attitudes affect positive interactions leading to the detriment of patient health

Serious climate change-related health problems will affect the world's population

More than 250 Montefiore physicians named Top Doctors by Castle Connolly

Introducing art into nursing care improves stroke survivors' QOL

Experts highlight latest advances in use of biomarkers in various diseases

Depression increases risk of death in PCI patients

UM, Shock Trauma partner to train dental students, residents

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

OHRI, uOttawa to lead first stem cell therapy trial for septic shock

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Health Canada approves Mylan-Rosuvastatin Calcium Tablets

Patients with early stage MPM may be eligible for aggressive multi-modality therapy

Light-to-moderate drinking may reduce risk of stroke in women

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

diaDexus fourth quarter total revenues increase 48% to $4.9 million

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter

Seeds for heart-healthy soybean, canola and sunflower oils

Shire enters agreement to acquire FerroKin BioSciences

China Pharma revenue increases 9% to $81.2M for full year 2011

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in